← FDA DRUG APPROVALS

FDA NDA · NDA022042

EVISTA

Sponsor: LILLY

APPLICATION
NDA022042
TYPE
NDA
ORIGINAL APPROVAL
2007-09-13
LATEST ACTION
2007-09-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

EVISTAPrescription
RALOXIFENE HYDROCHLORIDE 60MG · TABLET · ORAL

Approval history

2007-09-13Type 6 - New Indication (no longer used) · Original · standardReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →